US Stocks
/
Actuate Therapeutics, Inc. Share Price

Actuate Therapeutics, Inc. Share Price

NASDAQ: ACTU | Micro Cap
$0.61
-$0.06 (-9.08%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Actuate Therapeutics, Inc. Stock Performance

Open
$0.64
Prev. Close
$0.67
Circuit Range
N/A
Day Range
$0.61 - $0.64
Year Range
$0.61 - $8.40
Volume
775
Average Traded
$0.62

Actuate Therapeutics, Inc. Share Price Today

As of 10 October 2026, Actuate Therapeutics, Inc.'s share price is $0.61. The stock opened at $0.64, compared to its previous close of $0.67. During today's trading session, Actuate Therapeutics, Inc.'s share price traded between $0.61 and $0.64, with an average price of $0.62. Over the past 52 weeks, the stock has recorded a high of $8.40 and a low of $0.61. In terms of performance, Actuate Therapeutics, Inc.'s share price has declined by 79.02% over the last six months and is down 90.85% on a year-on-year basis.

Actuate Therapeutics, Inc. Share Price Chart

$0.61$0.64
L
Show Current Price
H

Actuate Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$12.83M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.85
Revenue (TTM)
$0.00
Return On Equity (TTM)
-2067.81%
Profit Margin
N/A
Debt to Equity
0.04
Quarterly Earnings Growth YoY
9.98%

Actuate Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$5.41-$4.55-$5.63-$4.87
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A15.90%-23.74%13.50%

Actuate Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$0.00
Net Profit-$27.29-$22.23
Net Profit MarginN/AN/A
Income ChangeN/A18.54%

About Actuate Therapeutics, Inc.

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.

Actuate Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$0.86
$0.61
-23.17%
Sep 2026
$1.45
$0.79
-53.84%
Aug 2026
$1.12
$1.72
+54.26%
Jul 2026
$1.50
$1.11
-25.67%
Jun 2026
$2.21
$1.50
-25.74%
May 2026
$3.10
$2.02
-30.58%
Apr 2026
$2.83
$2.91
+6.99%
Mar 2026
$3.60
$2.72
-28.42%
Feb 2026
$4.92
$3.80
-19.83%
Jan 2026
$6.01
$4.74
-22.30%
Dec 2025
$7.23
$6.10
-19.21%
Nov 2025
$6.52
$7.55
+13.19%

ACTU Share Price FAQs

What is Actuate Therapeutics, Inc. share price today?

chevron-up
Actuate Therapeutics, Inc. share price today is $0.61 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Actuate Therapeutics, Inc. stock?

chevron-up
The 52 week high of Actuate Therapeutics, Inc. stock is $8.40, while the 52 week low is $0.61 as of 10 Oct '26.

What is ACTU's market capitalisation today?

chevron-up
ACTU market capitalisation is $12.83M as of October 10, 2026, at 4:41 am IST.

What is ACTU's net income for the last quarter?

chevron-up
ACTU's net income for the last quarter is -4.87B USD.

What is the 5 year returns of ACTU?

chevron-up
The 5 year returns of ACTU is -92.42% as on 10 Oct '26.

What is the high & low stock price of ACTU today?

chevron-up
ACTU stock price hit a high of $0.64 and low of $0.61 as of 10 Oct '26.

Can I buy ACTU shares in India?

chevron-up
Yes. You can buy ACTU in India by opening an international trading account.